Olaparib combined with low-dose chemotherapy for relapsed <i>AML1::ETO</i> positive acute myeloid leukemia in elderly patient-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Olaparib combined with low-dose chemotherapy for relapsed AML1::ETO positive acute myeloid leukemia in elderly patient

Published:2024-07-02 Issue:8 Volume:65 Page:1181-1185
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Lin Li¹,Xue Song²^ORCID,Chen Jiaqi³^ORCID,Gu Cuihong¹,Zhang Jingzheng¹,Xing Enhong⁴,Wang Wei¹,Wang Lihong¹,Zhang Zhihua¹

Affiliation:

1. Department of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde, People’s Republic of China

2. Department of Bone Marrow Transplant, Beijing Lu Daopei Hospital, Beijing, People’s Republic of China

3. Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, People’s Republic of China

4. Department of Central Laboratory, The Affiliated Hospital of Chengde Medical College, Chengde, People’s Republic of China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2024.2337795

Reference19 articles.

1. Acute Myeloid Leukemia

2. Clonal evolution of acute myeloid leukemia from diagnosis to relapse

3. Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia

4. Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients

5. The impact of the combination of KIT mutation and minimal residual disease on outcome in t(8;21) acute myeloid leukemia

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP